Target
CA-125
6 abstracts
Abstract
Prognostic & predictive significance of pre- and post-operative plasma tumor markers in patients with appendiceal adenocarcinoma undergoing cytoreductive surgery: Insights from a single-center study.Org: University of Texas MD Anderson Cancer Center, University of Texas at MD Anderson Cancer Center, MD Anderson Cancer Center, Department of Analytics and Informatics, The University of Texas MD Anderson Cancer Center, Stem Cell Transplantation Rsch, Houston, TX,
Abstract
A novel three-biomarker signature (CA-62, CEA, CYFRA 21-1) and early-stage NSC lung cancer detection.Org: UCM Technologies Inc., Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry RAS, I.M.Sechenov First Moscow Medical University, IM Sechenov First Moscow State Medical University, Pacific Biosciences Research Centre,
Abstract
Oregovomab and non-platinum chemotherapy in PARP inhibitor-resistant ovarian, fallopian tube, or primary peritoneal cancer patients not candidates for platinum retreatment: A multicenter, two-cohort, single-arm phase 2 trial (OPERA/KGOG 3065/APGOT-OV6).Org: Yonsei University College of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Korea University College of Medicine, Seoul National University Bundang Hospital,
Abstract
Circulating tumor DNA (ctDNA) as a marker of residual disease and recurrence in resected stage I-IV epithelial ovarian cancer (EOC).Org: Peter MacCallum Cancer Centre, Melbourne, Australia, Epworth Healthcare, Western Health, Walter and Eliza Hall Institute of Medical Research, University of Melbourne,
Abstract
Serum tumor biomarkers as a surrogate for radiographic assessment of non-small cell lung cancer.Org: University of Western Ontario, London Regional Cancer Program, Schulich School of Medicine and Dentistry, Western University, Royal College of Surgeons in Ireland,
Abstract
Development and validation of prediction models for coexisting adnexa malignancy in patients with endometrial cancer using machine learning algorithm: A population-based cohort study.Org: Qilu Hospital of Shandong University, Jinan, China,